237 related articles for article (PubMed ID: 28767665)
21. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
22. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
23. Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency.
Nakajima T; Uehara T; Iwaya M; Kobayashi Y; Maruyama Y; Ota H
BMC Cancer; 2020 Apr; 20(1):319. PubMed ID: 32293346
[TBL] [Abstract][Full Text] [Related]
24. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
[No Abstract] [Full Text] [Related]
25. Prognostic and predictive role of DNA mismatch repair status in stage II-III colorectal cancer: A systematic review and meta-analysis.
Deng Z; Qin Y; Wang J; Wang G; Lang X; Jiang J; Xie K; Zhang W; Xu H; Shu Y; Zhang Y
Clin Genet; 2020 Jan; 97(1):25-38. PubMed ID: 31432497
[TBL] [Abstract][Full Text] [Related]
26. Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma.
Foda AA; Palicelli A; Shebl A; Boldorini R; Elnaghi K; ElHawary AK
Indian J Pathol Microbiol; 2019; 62(3):405-412. PubMed ID: 31361228
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
[TBL] [Abstract][Full Text] [Related]
28. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study.
Pina A; Wolber R; McAlpine JN; Gilks B; Kwon JS
Int J Gynecol Cancer; 2018 Oct; 28(8):1624-1630. PubMed ID: 30095707
[TBL] [Abstract][Full Text] [Related]
29. [Correlations between DNA mismatch repair (MMR) and prognosis and prediction of treatment efficacy in stage II/II colon cancer].
Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):844-8. PubMed ID: 25620482
[TBL] [Abstract][Full Text] [Related]
30. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
[TBL] [Abstract][Full Text] [Related]
31. Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients.
Cedrés S; Ponce-Aix S; Iranzo P; Callejo A; Pardo N; Navarro A; Martinez-Marti A; Gómez-Abecia S; Zucchiatti AC; Sansano I; Enguita AB; Miquel JM; Viaplana C; Dienstmann R; Paz-Ares L; Felip E
Clin Transl Oncol; 2020 Aug; 22(8):1390-1398. PubMed ID: 31916017
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry.
Zeng Z; Yan Q; Chen G; Zhang X; Huang J; Fu K; Peng X; Xiao S
Eur J Cancer Prev; 2021 May; 30(3):251-257. PubMed ID: 32826709
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
34. [Correlation of NTRK genetic fusions with mismatch repair protein deletion in patients with colorectal cancer].
Pu XH; Gao FP; Wu HY; Fu Y; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):103-107. PubMed ID: 35152627
[No Abstract] [Full Text] [Related]
35. A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer.
Chikatani K; Chika N; Suzuki O; Sakimoto T; Ishibashi K; Eguchi H; Okazaki Y; Ishida H
Anticancer Res; 2020 Aug; 40(8):4379-4385. PubMed ID: 32727766
[TBL] [Abstract][Full Text] [Related]
36. Clinico-pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology service.
Walsh MD; Jayasekara H; Huang A; Winship IM; Buchanan DD
Australas J Dermatol; 2019 May; 60(2):126-133. PubMed ID: 30506759
[TBL] [Abstract][Full Text] [Related]
37. Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan.
Chen JR; Chiang JM; Changchien CR; Chen JS; Tang RP; Wang JY
Br J Surg; 2008 Jan; 95(1):102-10. PubMed ID: 18064717
[TBL] [Abstract][Full Text] [Related]
38. Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.
Cheng AS; Leung SCY; Gao D; Burugu S; Anurag M; Ellis MJ; Nielsen TO
Breast Cancer Res Treat; 2020 Jan; 179(1):3-10. PubMed ID: 31522348
[TBL] [Abstract][Full Text] [Related]
39. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.
Ruiz I; Martín-Arruti M; Lopez-Lopez E; Garcia-Orad A
Gynecol Oncol; 2014 Jul; 134(1):20-3. PubMed ID: 24814467
[TBL] [Abstract][Full Text] [Related]
40. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]